Weiss to head
Will take cancer research, patient care to ‘next level’
Dr. Geoffrey Weiss, one of the nation’s
leading cancer researchers, has been appointed Chief of
the Division of Hematology-Oncology
and Deputy Director
of the Cancer
Center for Clinical Affairs and Clinical Research at the U.Va. Health System.
Weiss is a leader in bringing the newest discoveries
from the laboratory to the treatment of patients
and is a recognized expert in the clinical investigation
of new anti-cancer agents. His particular area of expertise involves the
of how the body’s immune system may be marshaled to fight cancer. He has
focused his research on the management of kidney cancers and other types of cancers
of the genital and urinary tracts. Among his accomplishments, Weiss has participated in the development
of interleukin-2 as a standard treatment for advanced kidney
cancer and for malignant melanoma, a serious form of skin cancer.
are excited to be working with one of the nation’s leading
experts in the development of cancer-fighting drugs,” said
Dr. Arthur “Tim” Garson Jr., vice president and dean
of U.Va.’s medical
school. “We look forward to his
arrival [later this fall], and we believe that he will help our
institution reach new heights in cancer research and treatment.”
Weiss will be joining a team of more than 40 U.Va. clinical
oncologists and over 150 laboratory investigators to help
lead a major expansion
of programs in both clinical cancer care and research.
In support of these efforts, the University will soon open
a new research
building, construct a new cancer center and substantially
increase the number of oncology faculty.
“While the Health System’s
cancer center is already designated a National Cancer Institute
(NCI) Clinical Cancer Center,
I expect to be a partner with cancer center leaders in the effort to
become an NCI Comprehensive Cancer Center,” Weiss said.
NCI designation means that a center is recognized nationally
for its excellence in research and patient care and for
its ability to provide
resources to the community and the region
focused on cancer and cancer-related problems.
coming to Virginia, I recognize that U.Va.’s Cancer Center
is already a great place to be
treated with excellent doctors committed to a team approach for care,” Weiss
said. “With the
advent of the new cancer center, we will be taking research and patient
care o the next level.”
comes to U.Va from the University of Texas Health Science Center
at San Antonio where he served as the chief of
the Division of Medical
as associate director for clinical
research of the San Antonio Cancer Institute.
joining the faculty there in 1982, Weiss received his M.D.
from St. Louis University, and completed
a residency in internal medicine at Temple University Hospital
and a fellowship in medical
oncology at Harvard University’s Dana-Farber Cancer Institute in Boston.
and his wife Martha have two children; 19-year-old Mark is
a student at Claremont-McKenna College in California,